Advertisement

Advances in Therapy

, Volume 21, Issue 5, pp 277–287 | Cite as

Group A β-hemolytic streptococcal pharyngitis in children

  • Alexander K. C. Leung
  • James D. Kellner
Article

Abstract

Group A β-hemolytic streptococcus (GABHS) is the most common bacterial cause of acute pharyngitis in children. Because clinical findings can be nonspecific, even experienced physicians cannot reliably diagnose GABHS pharyngitis solely on the basis of clinical presentation. Suspected cases should be confirmed by a throat culture or a rapid antigen detection test before antibiotic therapy is initiated. Microbiologic testing is generally not necessary in patients with pharyngitis whose clinical and epidemiologic findings are not suggestive of GABHS. Clinical score systems have been developed to help physicians decide which patients should undergo diagnostic testing and to reduce the unnecessary use of antibiotics. Antibiotic therapy should be initiated as soon as the diagnosis is confirmed. Penicillin V remains the drug of choice. Alternative therapy, eg, with cephalosporin or macrolide, is often sought because of penicillin allergy, noncompliance, and treatment failure.

Keywords

Group A β-hemolytic streptococcus pharyngitis microbiologic testing antimicrobial therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kiselica D. Group A beta-hemolytic streptococcal pharyngitis: current clinical concepts.Am Fam Physician. 1994;49:1147–1154.PubMedGoogle Scholar
  2. 2.
    Schroeder BM. Diagnosis and management of group A streptococcal pharyngitis.Am Fam Physician. 2003;67:880–884.PubMedGoogle Scholar
  3. 3.
    Lin MH, Fong WK, Chang PF, et al. Predictive value of clinical features in differentiating group A β-hemolytic streptococcal pharyngitis in children.J Microbiol Immunol Infect. 2003;36:21–25.PubMedGoogle Scholar
  4. 4.
    Schwartz RH, Gerber MA. Pharyngeal findings of group A streptococcal pharyngitis.Arch Pediatr Adolesc Med. 1998;152:927–928.PubMedGoogle Scholar
  5. 5.
    Bisno AL, Gerber MA, Gwaltney JM Jr, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis.Clin Infect Dis. 2002;35:113–125.PubMedCrossRefGoogle Scholar
  6. 6.
    McIsaac WJ, Goel V, Slaughter PM, et al. Reconsidering sore throats. Part 2: alternative approach and practical office tool.Can Fam Physician. 1997;47:495–500.Google Scholar
  7. 7.
    McIsaac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adults.JAMA. 2004;291:1587–1595.PubMedCrossRefGoogle Scholar
  8. 8.
    Shulman ST, Tanz RR.Streptococcus pyogenes (group A streptococcus). In: Long SS, Pickering LK, Prober CG, eds.Principles and Practice of Pediatric Infectious Diseases. Philadelphia, Pa: Churchill Livingstone; 2003:716–719.Google Scholar
  9. 9.
    Fischett VA. Streptococcal M protein: molecular design and biological behavior.Clin Microbiol Rev. 1989;2:285–314.Google Scholar
  10. 10.
    Gerber MA. Group A streptococcus. In: Behrman RE, Kliegman RM, Jenson HB, eds.Nelson Textbook of Pediatrics. Philadelphia, Pa: WB Saunders; 2004:870–874.Google Scholar
  11. 11.
    Nussinovitch M, Finkelstein Y, Amir J, et al. Group A beta-hemolytic streptococcal pharyngitis in preschool children aged 3 months to 5 years.Clin Pediatr. 1999;38:357–360.CrossRefGoogle Scholar
  12. 12.
    Tarlow MJ. Macrolides in the management of streptococcal pharyngitis/tonsillitis.Pediatr Infect Dis J. 1997;16:444–448.PubMedCrossRefGoogle Scholar
  13. 13.
    American Academy of Pediatrics. Group A streptococcal infections. In: Pickering LK, ed.Red Book: 2003 Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 2003:573–584.Google Scholar
  14. 14.
    Gerber MA. Treatment failures and carriers: perception or problems?Pediatr Infect Dis J. 1994;13: 576–579.PubMedGoogle Scholar
  15. 15.
    Pichichero ME, Marocci SM, Murphy ML, et al. Incidence of streptococcal carriers in private pediatric practice.Arch Pediatr Adolesc Med. 1999;153:624–628.PubMedGoogle Scholar
  16. 16.
    Leung AK. Streptococcal pharyngitis.HK J Pediatr. 1985;2:214–219.Google Scholar
  17. 17.
    Leung AK, Pinto-Rajas A. Infectious mononucleosis.Consultant. 2000;40:134–136.Google Scholar
  18. 18.
    Breese BB. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis.Am J Dis Child. 1977;131:514–517.PubMedGoogle Scholar
  19. 19.
    Centor RM, Witherspoon JM, Dalton HP, et al. The diagnosis of strept throat in adults in the emergency room.Med Decis Making. 1981;1:239–246.PubMedCrossRefGoogle Scholar
  20. 20.
    McIsaac WJ, White D, Tannenbaum D, et al. A clinical score to reduce unnecessary antibiotic use in patients with sore throat.Can Med Assoc J. 1998;158:75–83.Google Scholar
  21. 21.
    Wald ER, Green MD, Schwartz B, et al. A streptococcal score card revisited.Pediatr Emerg Care. 1998;14:109–111.PubMedCrossRefGoogle Scholar
  22. 22.
    Lopez R. Diagnosing streptococcal pharyngitis.Am J Dis Child. 1979;133:449.PubMedGoogle Scholar
  23. 23.
    Gerber MA. Diagnosis of group A streptococcal pharyngitis.Pediatr Ann. 1998;27:269–273.PubMedGoogle Scholar
  24. 24.
    Nawaz H, Smith DS, Mazhari R, et al. Concordance of clinical findings and clinical judgment in the diagnosis of streptococcal pharyngitis.Acad Emerg Med. 2000;7:1104–1109.PubMedCrossRefGoogle Scholar
  25. 25.
    Douglas M, Stralnick H. A scoring system for streptococcal pharyngitis.J Fam Pract. 1996;43: 537–538.PubMedGoogle Scholar
  26. 26.
    Hayden GF, Turner RB. Pharyngitis. In: Jenson HB, Baltimore RS, eds.Pediatric Infectious Diseases: Principles and Practice. Philadelphia, Pa: WB Saunders; 2002:711–720.Google Scholar
  27. 27.
    Corneli HM. Rapid detection and diagnosis of group A streptococcal pharyngitis.Curr Infect Dis Report. 2004;6:181–186.CrossRefGoogle Scholar
  28. 28.
    Ehrlich JE, Demopoulos BP, Daniel KR, et al. Cost-effectiveness of treatment options for prevention of rheumatic heart disease from group A streptococcal pharyngitis in a pediatric population.Prev Med. 2002;35:250–257.PubMedCrossRefGoogle Scholar
  29. 29.
    Webb KH, Needham CA, Kurtz SR. Use of a high-sensitivity rapid test without culture confirmation of negative results: 2 years’ experience.J Fam Pract. 2000;49:34–38.PubMedGoogle Scholar
  30. 30.
    Shulman ST. Complications of streptococcal pharyngitis.Pediatr Infect Dis J. 1994;13:S70-S74.PubMedGoogle Scholar
  31. 31.
    Block SL. Short-course antimicrobial therapy of streptococcal pharyngitis.Clin Pediatr. 2003;42: 663–671.CrossRefGoogle Scholar
  32. 32.
    Gooch WM. Potiential infectious disease complications of upper respiratory tract infections.Pediatr Infect Dis J. 1998;17:S79-S82.PubMedCrossRefGoogle Scholar
  33. 33.
    Chmelik E, Awadallah N, Hadi FS, et al. Varied presentation of PANDAS: a case series.Clin Pediatr. 2004;43:379–382.CrossRefGoogle Scholar
  34. 34.
    Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS).Arch Pediatr Adolesc Med. 2002;156:356–361.PubMedGoogle Scholar
  35. 35.
    Robson WL, Leung AK. Post-streptococcal glomerulonephritis.Can Fam Physician. 1992;38: 2883–2887.PubMedGoogle Scholar
  36. 36.
    Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background.Ann Intern Med. 2001;134:509–517.PubMedGoogle Scholar
  37. 37.
    Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy.JAMA. 1985;253:1271–1274.PubMedCrossRefGoogle Scholar
  38. 38.
    El-Daher NT, Hijazi SS, Rawashdeh NM, et al. Immediate vs delayed treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin V.Pediatr Infect Dis J. 1991;10:126–130.PubMedGoogle Scholar
  39. 39.
    Pichichero ME, Disney FA, Talpey WB, et al. Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin.Pediatr Infect Dis J. 1987;6:635–643.PubMedGoogle Scholar
  40. 40.
    Kaplan EL. Delayed treatment for strept throat.Pediatr Infect Dis J. 1987;6:1140.PubMedGoogle Scholar
  41. 41.
    Gerber MA, Randolph MF, DeMeo KK, et al. Lack of impact of early antibiotic therapy for streptococcal pharyngitis on recurrence rates.J Pediatr. 1990;117:853–858.PubMedCrossRefGoogle Scholar
  42. 42.
    Leung AK, Robson WL, Jadavji T. Antibiotic dosages in the treatment of group A streptococcal infections.Clin Pediatr. 1992;31:447.CrossRefGoogle Scholar
  43. 43.
    Schwartz RH, Wientzen RL Jr, Pedreira F, et al. Penicillin V for group A streptococcal pharyngotonsillitis: a randomized trial of seven vs ten days’ therapy.JAMA. 1981;246:1790–1795.PubMedCrossRefGoogle Scholar
  44. 44.
    Gerber MA, Randolph MF, Chanatry J, et al. Five vs ten days of penicillin V therapy for streptococcal pharyngitis.Am J Dis Child. 1987;141:224–227.PubMedGoogle Scholar
  45. 45.
    Bycroft TC, O’Connor T, Hoff C, et al. When choosing injectable penicillin for the treatment of group A beta-hemolytic streptococcal pharyngitis, there is a less painful choice.Pediatr Emerg Care. 2000;16:398–400.PubMedCrossRefGoogle Scholar
  46. 46.
    Hayden GF, Turner RB. Acute pharyngitis. In: Behrman RE, Kliegman RM, Jenson HB, eds.Nelson Textbook of Pediatrics. Philadelphia, Pa: WB Saunders; 2004:1393–1394.Google Scholar
  47. 47.
    Feder HM Jr, Gerber MA, Randolph MF, et al. Once-daily therapy for streptococcal pharyngitis with amoxicillin.Pediatrics. 1999;103:47–51.PubMedCrossRefGoogle Scholar
  48. 48.
    Gopichand I, Williams GD, Medendorp SV, et al. Randomized, single-blinded comparative study of the efficacy of amoxicillin (40 mg/kg/day) versus standard-dose penicillin V in the treatment of group A streptococcal pharyngitis in children.Clin Pediatr. 1993;37:341–346.CrossRefGoogle Scholar
  49. 49.
    Shvartzman P, Tabenkin H, Rosentzwaig A, et al. Treatment of streptococcal pharyngitis with amoxycillin once a day.BMJ. 1993;306:1170–1172.PubMedCrossRefGoogle Scholar
  50. 50.
    Klein JO. Management of streptococcal pharyngitis.Pediatr Infect Dis J. 1994;13:572–575.PubMedGoogle Scholar
  51. 51.
    Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults.Clin Infect Dis. 2004;39:1526–1534.CrossRefGoogle Scholar
  52. 52.
    Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and Augmentin in the treatment of upper respiratory tract infections.Drugs Exp Clin Res. 1987;13:91–94.PubMedGoogle Scholar
  53. 53.
    Esposito S, Marchisio P, Bosis S, et al. Comparative efficacy and safety of 5-day cefaclor and 10-day amoxycillin treatment of group A streptococcal pharyngitis in children.Int J Antimicrob Agents. 2002;20:28–33.PubMedCrossRefGoogle Scholar
  54. 54.
    Milatovic D. Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis.Pediatr Infect Dis J. 1991;10:S61-S63.PubMedGoogle Scholar
  55. 55.
    Portier H, Chavanet P, Gouyon JB, et al. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.J Antimicrob Chemother. 1990;26(suppl E):79–85.PubMedGoogle Scholar
  56. 56.
    Seppala H, Nissinen A, Jarvinen H, et al. Resistance to erythromycin in group A streptococci.N Engl J Med. 1992;326:292–297.PubMedCrossRefGoogle Scholar
  57. 57.
    Brook I, Aronovitz GH, Pichichero ME. Open-label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/ tonsillitis.Clin Therapeut. 2001;23:1888–1990.Google Scholar
  58. 58.
    McCarty J, Hedrick JA, Gooch WM. Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis.Adv Ther. 2000;17:14–26.PubMedGoogle Scholar
  59. 59.
    Schaad UB, Kellerhals P, Altwegg M, et al. Azithromycin versus penicillin V for treatment of acute group A streptococcal pharyngitis.Pediatr Infect Dis J. 2002;21:304–308.PubMedCrossRefGoogle Scholar
  60. 60.
    McCracken GH Jr. Diagnosis and management of children with streptococcal pharyngitis.Pediatr Infect Dis. 1986;5:754–759.PubMedCrossRefGoogle Scholar
  61. 61.
    Tanz RR, Shulman ST. Streptococcal pharyngitis: the carrier state, definition, and management.Pediatr Ann. 1998;27:281–285.PubMedGoogle Scholar
  62. 62.
    Pichichero M. Recurrent streptococcal pharyngitis: indications for tonsillectomy and penicillin prophylaxis.Pediatr Infect Dis J. 1994;13:83–84.PubMedCrossRefGoogle Scholar
  63. 63.
    Paradise JL, Bluestone CD, Bachman RZ, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children: results of parallel randomized and nonrandomized clinical trials.N Engl J Med. 1984;310:674–683.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science and Business Media and LLC 2004

Authors and Affiliations

  • Alexander K. C. Leung
    • 1
  • James D. Kellner
    • 1
  1. 1.Department of PediatricsUniversity of Calgary Alberta Children’s HospitalCalgaryCanada

Personalised recommendations